Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Ulcerative Colitis
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug, Procedure
Participants:
70
Start Date:
August 8, 2021
A Randomized and Placebo-Controlled Phase II Trial Targeting Dominant-Negative Missense Mutant P53 by Atorvastatin for Reducing the Risk of Longstanding Ulcerative Colitis-Associated Cancer
Clinical Trial
Status:
Not yet recruiting
Intervention Type:
Diagnostic Test
Participants:
160
Start Date:
June 2021
The Validity of Novel Non-invasive Inflammatory Markers for Monitoring of Patients With Ulcerative Colitis
Search for trials
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
120
Start Date:
May 2021
Impact of Anti-cytomegalovirus (Valganciclovir) Treatment in the Management of Relapsing Ulcerative Colitis (UC) Requiring Vedolizumab Therapy: a Randomized Clinical Trial Comparing a Strategy With or Without Antiviral Therapy.
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 4
Intervention Type:
Biological
Participants:
10
Start Date:
May 1, 2021
Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Ulcerative Colitis
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 4
Intervention Type:
Drug
Participants:
150
Start Date:
April 30, 2021
A Multicenter, Single-arm, Open-label, Phase 4 Study to Evaluate the Safety and Efficacy of Vedolizumab in Indian Patients With Ulcerative Colitis and Crohn's Disease
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
1100
Start Date:
April 20, 2021
A Phase 3b, Randomized, Double-Blind, Parallel-Arm, Placebo- and Active- Controlled Treat-Through Study of Mirikizumab and Vedolizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
120
Start Date:
April 17, 2021
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Other
Participants:
48
Start Date:
April 15, 2021
Assessing Whether Buttermilk Powder Improves Disease Activity in Pediatric IBD
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Other
Participants:
10
Start Date:
April 15, 2021
Efficacy of Visceral Osteopathic Approach to Relieve Recurring Digestive Symptoms in Subjects With Inflammatory Bowel Diseases (IBS)
Clinical Trial
Status:
Not yet recruiting
Participants:
400
Start Date:
April 2021
Global IBD Visualization of Epidemiology Studies (GIVES) in the 21st Century (GIVES-21)
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
162
Start Date:
April 2021
A Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects With Moderately Active Ulcerative Colitis
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 4
Intervention Type:
Drug
Participants:
70
Start Date:
April 2021
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets n Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
Showing 1-12 of 368
Next